Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

67.91 -1.53 (-2.20%)
Streaming Delayed Price Updated: 2:16 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,238,150
Open 69.98
Bid (Size) 67.90 (12)
Ask (Size) 67.92 (3)
Prev. Close 69.44
Today's Range 67.80 - 70.00
52wk Range 66.88 - 148.15
Shares Outstanding N/A
Dividend Yield 1.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Novo Nordisk Shares Data From Injectable Ozempic, Oral Weight Loss Drug
Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL trial finds Rybelsus lowers cardiovascular risk by 14%. 
Via Benzinga

Performance

YTD
-22.4%
-22.4%
1 Month
-24.0%
-24.0%
3 Month
-20.8%
-20.8%
6 Month
-43.0%
-43.0%
1 Year
-46.8%
-46.8%

More News

Read More
Which Healthcare Stock Is the Best Buy Right Now?
Via MarketBeat
US Stocks Likely To Open Lower After 3-Day Fall: 'Equity Drawdown Probability Hasn't Peaked Yet,' Says Goldman Sachs Analyst
Via Benzinga
While Wall Street Panicked, These 3 Hidden Small-Caps Exploded Last Week — One Surging A Jaw-Dropping 60%
Via Benzinga
Topics Economy
Exposures Economy Interest Rates
Competitive Analysis In The ATTR-CM Field
Via Talk Markets
Topics Stocks / Equities
Is Hims & Hers Stock Too Cheap to Pass Up?
Via The Motley Fool
Benzinga Bulls And Bears: Chevron, Microsoft, Nike — And Tariffs Have Automotive Sector Reeling
Via Benzinga
Deal Dispatch: Bezos-Backed Crop Company Wilts, Tech Startup Nabs Napster For $207 Million
Via Benzinga
Novo Nordisk Stock Slips After BofA, Morgan Stanley Slash Price Targets – But Retail Goes Contrarian
Via Stocktwits
Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1
Via Investor's Business Daily
Penny Stock Lexicon Pharmaceuticals Surges On Obesity Pact Worth $1 Billion With Novo Nordisk
Via Benzinga
Is Hims & Hers Health Stock a Smart Buy After Plunging More Than 50%?
Via The Motley Fool
Topics Earnings
Exposures Financial Product Safety
Why Novo Nordisk Stock Dipped on Thursday
Via The Motley Fool
1 Growth Stock Down 40% to Buy and Hold Forever
Via The Motley Fool
Looking for growth without the hefty price tag? Consider NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO).
Via Chartmill
Novo Nordisk Stock Sinks To 52-Week Lows: Weight Loss Boom Losing Steam?
Via Benzinga
EXCLUSIVE: Vivani Medical Subdermal Semaglutide Implant Shows 20% Weight Loss In Animal Study, With Potential For Once-Yearly Dosing
Via Benzinga
Is Novo Nordisk Stock a Buy?
Via The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Novo Nordisk Signs $2B Deal For Obesity Drug With Chinese Biotech: Retail Sentiment Improves
Via Stocktwits
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk
From Faruqi & Faruqi, LLP
Via Business Wire
Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped
Via The Motley Fool
Motley Fool 2025 March Market Cap Showdown Championship
Via The Motley Fool
Novo Nordisk To Pay Around $2 Billion For Obesity Drug From China-Based Biotech
Via Benzinga

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 67.91
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 04/01/25 02:16 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.